NAPKON Pediatrics Module
1.0.0 - trial-use
NAPKON Pediatrics Module - Local Development build (v1.0.0). See the Directory of published versions
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="napkon-pediatrics-module"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system https://www.napkon.de/fhir/CodeSystem/napkon-pediatrics-module defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">P1<a name="napkon-pediatrics-module-P1"> </a></td><td>Sphingosine analogue</td></tr><tr><td style="white-space:nowrap">P2<a name="napkon-pediatrics-module-P2"> </a></td><td>Interleukin 2 receptor antagonist</td></tr><tr><td style="white-space:nowrap">P3<a name="napkon-pediatrics-module-P3"> </a></td><td>Interleukin 17 receptor antagonist</td></tr><tr><td style="white-space:nowrap">P4<a name="napkon-pediatrics-module-P4"> </a></td><td>Anti-CD20 antibody</td></tr><tr><td style="white-space:nowrap">P5<a name="napkon-pediatrics-module-P5"> </a></td><td>Anti-CD52 antibody</td></tr><tr><td style="white-space:nowrap">P6<a name="napkon-pediatrics-module-P6"> </a></td><td>Anti-CD3 antibody</td></tr><tr><td style="white-space:nowrap">P7<a name="napkon-pediatrics-module-P7"> </a></td><td>Anti-CD3/CD19 antibody</td></tr><tr><td style="white-space:nowrap">P8<a name="napkon-pediatrics-module-P8"> </a></td><td>Integrin inhibitor</td></tr><tr><td style="white-space:nowrap">P9<a name="napkon-pediatrics-module-P9"> </a></td><td>B cell activating factor inhibitor</td></tr><tr><td style="white-space:nowrap">P10<a name="napkon-pediatrics-module-P10"> </a></td><td>Mammalian target of rapamycin (mTOR)-Kinase inhibitor</td></tr></table></div>
</text>
<url value="https://www.napkon.de/fhir/CodeSystem/napkon-pediatrics-module"/>
<version value="1.0.0"/>
<name value="NapkonPediatricsModule"/>
<title value="NapkonPediatricsModule"/>
<status value="active"/>
<date value="2021-12-03"/>
<publisher value="Charité - Universitätsmedizin Berlin"/>
<contact>
<telecom>
<system value="url"/>
<value
value="https://www.bihealth.org/en/research/core-facilities/interoperability/"/>
</telecom>
</contact>
<description
value="NAPKON Pediatrics Module Code System - Collection of pediatrics module-specific codes that are missing from common terminologies such as SNOMED CT"/>
<content value="complete"/>
<count value="10"/>
<concept>
<code value="P1"/>
<display value="Sphingosine analogue"/>
</concept>
<concept>
<code value="P2"/>
<display value="Interleukin 2 receptor antagonist"/>
</concept>
<concept>
<code value="P3"/>
<display value="Interleukin 17 receptor antagonist"/>
</concept>
<concept>
<code value="P4"/>
<display value="Anti-CD20 antibody"/>
</concept>
<concept>
<code value="P5"/>
<display value="Anti-CD52 antibody"/>
</concept>
<concept>
<code value="P6"/>
<display value="Anti-CD3 antibody"/>
</concept>
<concept>
<code value="P7"/>
<display value="Anti-CD3/CD19 antibody"/>
</concept>
<concept>
<code value="P8"/>
<display value="Integrin inhibitor"/>
</concept>
<concept>
<code value="P9"/>
<display value="B cell activating factor inhibitor"/>
</concept>
<concept>
<code value="P10"/>
<display value="Mammalian target of rapamycin (mTOR)-Kinase inhibitor"/>
</concept>
</CodeSystem>